Abstract:Some women take medication during pregnancy to address a variety of clinical conditions. Because of ethical and logistical concerns, it is impossible to determine fetal drug exposure, and therefore fetal risk, during pregnancy. Hence, alternative approaches need to be developed to predict maternal-fetal drug exposure throughout pregnancy. To do so, we previously developed and verified a maternal-fetal physiologically based pharmacokinetic model, which can predict fetal exposure to drugs that passively cross the placenta. However, many drugs are actively transported by the placenta (e.g., human immunodeficiency virus protease inhibitors). To extend our maternal-fetal physiologically based pharmacokinetic model to these actively transported drugs, we determined the gestational age–dependent changes in the protein abundance of placental transporters. Total cellular membrane fractions from first trimester (T1; n = 15), second trimester (T2; n = 19), and term (n = 15) human placentae obtained from uncomplicated pregnancies were isolated by ultracentrifugation. Transporter protein abundance was determined by targeted quantitative proteomics using liquid chromatography tandem mass specrometry. We observed that breast cancer resistance protein and P-glycoprotein abundance significantly decreased from T1 to term by 55% and 69%, respectively (per gram of tissue). Organic anion–transporting polypeptide (OATP) 2B1 abundance significantly decreased from T1 to T2 by 32%. In contrast, organic cation transporter (OCT) 3 and organic anion transporter 4 abundance significantly increased with gestational age (2-fold from T1 to term, 1.6-fold from T2 to term). Serotonin transporter and norepinephrine transporter did not change with gestational age. The abundance of bile salt export pump, multidrug resistance-associated protein 1-5, Na+-taurocholate cotransporting polypeptide, OATP1B1, OATP1B3, OCTN1-2, concentrative nucleoside transporter 1-3, equilibrative nucleoside transporter 2, and multidrug and toxin extrusion 1 could not be quantified. These data can be incorporated into our maternal-fetal physiologically based pharmacokinetic model to predict fetal exposure to drugs that are actively transported across the placenta.SIGNIFICANCE STATEMENTWe quantified the protein abundance of key placental uptake and efflux transporters [organic cation transporter (OCT) 3, P-glycoprotein (P-gp), breast cancer resistance protein (BCRP)] across gestational ages (first trimester, second trimester, and term) using quantitative targeted proteomics. We observed that the protein abundance of P-gp and BCRP decreased, whereas that of OCT3 increased with gestational age. Incorporating the protein abundance determined in this study into maternal-fetal physiologically based pharmacokinetic model can help us better predict fetal drug exposure to substrates of these transporters.

Expression of CYP3A23/1, CYP3A2, PXR, CAR and HNF4alpha in Large-for-gestational-age Neonatal Rats.

Effects Of Intrauterine Undernutrition On The Expression Of Cyp3a23/3a1, Pxr, Car And Hnf4 Alpha In Neonate Rats

Peg-Rhgh Therapy for Small for Gestational Age Rats and Effects on Their Metabolic Parameters

Effects of Intrauterine Growth Restriction and High-Fat Diet on Serum Lipid and Transcriptional Levels of Related Hepatic Genes in Rats

Expression of Ghrelin and Calcium Channels in Pancreas of Neonatal Rats with Different Birth Weight

The Levels of Pdx1/insulin, Cacna1c and Cacna1d, and Β-Cell Mass in a Rat Model of Intrauterine Undernutrition

Extrauterine Growth Restriction on Pulmonary Vascular Endothelial Dysfunction in Adult Male Rats: the Role of Epigenetic Mechanisms

Effect of Maternal Lipid Profile, C-peptide, Insulin, and HBA1c Levels During Late Pregnancy on Large-for-gestational Age Newborns

Analysis of Gene Expression Profiles in the Liver of Rats With Intrauterine Growth Retardation

Associations of AHR, CYP1A1, EPHX1, and GSTP1 Genetic Polymorphisms with Small-for-gestational-age Infants

Altered DNA methylation in neonates born large-for-gestational-age is associated with cardiometabolic risk in children.

ERRγ1 and Aromatase Expression in Human Placental Tissues from Term Deliveries of Large for Gestational Age (LGA) Newborns

The Effects of A High-Fat and High-Energy Diet on the Hepatic Expression of Cyp3a in Developing Female Rats

Cord Blood C-peptide, Insulin, HbA1c, and Lipids Levels in Small- and Large-for-Gestational-Age Newborns

A High-Fat High-Energy Diet Influences Hepatic CYP3A Expression and Activity in Low-Birth-weight Developing Female Rats

Differences in cytochrome p450 enzyme expression and activity in fetal and adult tissues

Identification of Lncrna Expression Profiles and Analysis of Cerna in the Hippocampus of Perinatal Glyphosate-Exposed Mice.

Developmental Regulation of CYP3A4 and CYP3A7 in Chinese Han Population.

Prenatal ethanol exposure induces dynamic changes of expression and activity of hepatic cytochrome P450 isoforms in male rat offspring

Intrauterine Hyperglycemia Induces Hepatic Steatosis in Mouse Offspring Via Altered Lipid Gene Expressions

Gestational Age–Dependent Abundance of Human Placental Transporters as Determined by Quantitative Targeted Proteomics